MYGN
Myriad Genetics Inc
4.50$
+11.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1995 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +130.3% | +52.6% | +9.1% | +34.4% | +32.8% | +19.2% | +19.5% | -11.9% | +45.5% | +38.7% | +37.5% | +41.8% | +46.5% | +11.1% | +10.9% | +23.4% | +23.6% | +26.9% | -7.1% | +2.4% | -1.6% | +2.1% | +14.4% | -34.6% | +24.0% | -1.8% | +11.0% | +11.2% | -1.6% | |
| – | – | – | – | – | +954.9% | +44.8% | +17.1% | +9.5% | +47.8% | +36.0% | +11.5% | +5.0% | +33.8% | +2.4% | +5.5% | +38.4% | +23.1% | +37.2% | +35.0% | +6.7% | +8.8% | +3.5% | +13.4% | -11.3% | +10.9% | +2.2% | +16.9% | +6.8% | -1.7% | |
| – | +112.2% | +44.3% | +1.2% | +31.1% | +13.4% | +14.2% | +20.1% | -17.1% | +44.7% | +39.5% | +45.8% | +50.8% | +48.7% | +12.4% | +11.6% | +21.4% | +23.7% | +25.4% | -13.9% | +1.3% | -4.4% | +1.6% | +14.8% | -41.7% | +30.1% | -3.4% | +8.5% | +13.2% | -1.5% | |
| – | +43.1% | +23.7% | +2.2% | +19.6% | +20.4% | +7.3% | +31.1% | +6.5% | +16.9% | +41.4% | +20.2% | +38.7% | -87.2% | +22.1% | +26.9% | +53.7% | +25.9% | +25.6% | +11.9% | -6.5% | +5.4% | -4.8% | +21.3% | -5.8% | +1.2% | +4.3% | +3.9% | +27.8% | -5.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +20.9% | +29.9% | – | – | – | – | – | -8.9% | +6.0% | -53.9% | +14.4% | -2.7% | -6.9% | |
| – | +74.9% | +27.4% | -0.8% | +18.7% | +13.5% | +21.4% | +28.1% | +8.1% | +20.2% | +28.6% | +31.6% | -25.9% | +21.6% | +16.9% | +7.8% | +27.0% | +21.7% | +29.1% | +11.9% | -2.7% | +19.5% | -13.4% | +44.5% | +1.7% | +4.6% | -12.2% | +10.2% | +1.8% | -4.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +105.3% | +6.8% | +16.8% | +14.3% | +26.4% | +20.4% | -51.1% | +14.3% | -71.3% | +177.0% | -93.8% | -2,663.2% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +50.0% | +1,900.0% | -46.7% | +275.0% | -10.0% | -38.9% | -51.5% | -9.4% | -3.4% | +275.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +81.9% | +3.2% | +13.4% | +15.6% | +26.4% | +19.1% | -51.5% | +15.6% | -76.8% | +231.8% | -93.6% | -3,784.4% | – | – | – | – | – | |
| – | +55.9% | +6.5% | +2.0% | -12.8% | -93.3% | -14.3% | -16.6% | -583.2% | – | – | – | -98.3% | -68.3% | -6,042.5% | – | +22.8% | +19.0% | +18.0% | -46.2% | -29.1% | -51.0% | -168.4% | – | – | – | – | – | +245.5% | -868.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +76.9% | +80.0% | -33.9% | +11.4% | +31.2% | +19.8% | -54.5% | +46.1% | -85.2% | +666.1% | -96.5% | -4,963.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +93.1% | +4.6% | +16.1% | +14.8% | +25.1% | +21.7% | -44.5% | +14.4% | -50.6% | +96.4% | -52.2% | -245.2% | – | -788.6% | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.